Skip to main content
. 2019 Mar 27;12:1756286419835077. doi: 10.1177/1756286419835077

Figure 2.

Figure 2.

TSQM-9: Changes in effectiveness, convenience, and global satisfaction scores from study entry to 24 months for patients receiving teriflunomide who discontinued previous DMT within 6 months of study entry.

***p < 0.001.

DMT, disease-modifying therapy; TSQM-9, Treatment Satisfaction Questionnaire.